Glenmark Life Sciences Limited logo

Glenmark Life Sciences Limited

NSE:GLS.NS

Overview | Financials
Company Name Glenmark Life Sciences Limited
Symbol GLS.NS
Currency INR
Price 1,096.1
Market Cap 134,308,421,300
Dividend Yield 2.74%
52-week-range 620.2 - 1,335.1
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Yasir Yusufali Rawjee Ph.D.
Website https://www.glenmarklifesciences.com

An error occurred while fetching data.

About Glenmark Life Sciences Limited

Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin

Related Stocks

Caplin Point Laboratories Limited logo

Caplin Point Laboratories Limited

CAPLIPOINT.NS

2,011.8 INR

Hikal Limited logo

Hikal Limited

HIKAL.NS

386.95 INR

Sun Pharma Advanced Research Company Limited logo

Sun Pharma Advanced Research Company Limited

SPARC.NS

207.44 INR

FDC Limited logo

FDC Limited

FDC.NS

514.4 INR

Vijaya Diagnostic Centre Limited logo

Vijaya Diagnostic Centre Limited

VIJAYA.NS

1,119.45 INR

Granules India Limited logo

Granules India Limited

GRANULES.NS

584.5 INR

Aarti Drugs Limited logo

Aarti Drugs Limited

AARTIDRUGS.NS

490 INR

Jubilant Pharmova Limited logo

Jubilant Pharmova Limited

JUBLPHARMA.NS

1,239 INR

HealthCare Global Enterprises Limited logo

HealthCare Global Enterprises Limited

HCG.NS

467.6 INR

Wockhardt Limited logo

Wockhardt Limited

WOCKPHARMA.NS

1,236.3 INR

Financials

Numbers are in millions USD

Numbers are in millions USD